Homocysteine Testing: Market Insights
Homocysteine is a building block of protein i.e. a common amino acid that produced in the blood. High levels of homocysteine can lead to the early development of heart-related disorders, renal disease, and can cause deficiency of vitamins B6, vitamin B12, and folate.
Homocysteine testing can be simply measured doing a blood test. Generally, vitamin B6, vitamin B12, and folate break down homocysteine and convert it into other substances. The body receives homocysteine mostly from meat. Growing meat consumption has increased the level of homocysteine in the body.
This has upsurge the risk of heart and renal disease and deficiency of vitamin B6, vitamin B6 and folic acid in the body of an individual. To reduce the burden, regular homocysteine testing is required which can be detected through a simple blood test. Hence, it is recommended to do the body checkup and blood testing at least once in three months.
Homocysteine Testing: Market Dynamics
Rising geriatric population, increasing alcohol consumption, smoking, and use of vitamin B supplements are some of the driving factor for propelling the growth of homocysteine testing market. The world’s ageing population is growing at an unprecedented rate. Today, around 8.5% of the population are over 65 years and above, globally.
This significantly will increase the growth of homocysteine testing market in the forecast period. Additionally, the rise in disposable income is increasing the treatment-seeking rate after diagnosis. This factor is expected to propel the growth of the homocysteine testing market.
However, unsymptomatic nature and unable to detect the high level of homocysteine at an early stage can lead to severe heart conditions and may hamper the growth of the homocysteine testing market. Also, unawareness regarding the deficiency of vitamins in the blood until becoming severe may limit the growth of the homocysteine testing market.
Homocysteine Testing: Overview
High level of homocysteine usually shows a deficiency in vitamin B12 or folic acid. In blood, a normal homocysteine level should be less than 15 micromoles/litre of blood. Higher homocysteine levels can be categorized into moderate in which homocysteine level is ~15-30 micromoles/litre of blood, intermediate in which homocysteine level reach ~30-100 micromoles/litre of blood, and severe in which homocysteine level reach more than 100 micromoles/litre of blood.
If an individual detected with a high level of homocysteine, some other homocysteine testing is required to done to confirm the homocysteine level. Moreover, poor lifestyle, changing demographics, and increasing junk food consumption are some of the key factors driving the market growth of homocysteine testing market.
Homocysteine Testing: Region-wise Outlook
The Asia-Pacific homocysteine testing market is expected to grow at a moderate growth, however, is likely to show a large patient pool in the forecast years. This is because of a high percentage of the population lack awareness regarding the management of the level of homocysteine testing, which restricts them to opt for homocysteine testing.
This factor is expected to hamper the market growth of homocysteine testing in the region. The North America market is expected to show high homocysteine testing market growth because the compliance rate of blood testing in the region is high coupled with progressive healthcare infrastructure and large treatment-seeking population in the region.
Europe market will be in second place in the homocysteine testing market due to the high adoption rate for homocysteine testing.
Homocysteine Testing: Key Players
Some of the key players present in global homocysteine testing market are Mylan Pharmaceuticals, Bristol-Myers Squibb Company, Novartis International AG, Teligent, Inc., Pfizer Inc., Cardinal Health, Inc., McKesson Corporation, Jamp Pharma Corporation, Kripps Pharmacy Ltd, and others.
The report covers exhaustive analysis on
- Homocysteine Testing Market Segments
- Homocysteine Testing Market Dynamics
- Homocysteine Testing Market Size
- Homocysteine Testing Current Trends/Issues/Challenges
- Homocysteine Testing Competition & Companies involved
- Homocysteine Testing Value Chain
The regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Russia, Rest of Europe)
- East Asia (China, Japan, South Korea)
- South Asia (India, Indonesia, Malaysia, Rest of East Asia)
- Middle East and Africa (N. Africa, S. Africa, Israel, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Homocysteine Testing: Segmentation
The global homocysteine testing market is segmented by type, drug type, form, distribution channel, and regions:
Homocysteine Testing Segmentation by Type
- Moderate (15 to 30 µmol/L)
- Intermediate (30 to 100 µmol/L)
- Severe (greater than 100 µmol/L)
Homocysteine Testing Segmentation by Drug Type
- Folic Acid
Homocysteine Testing Segmentation by Form
Homocysteine Testing Segmentation by Distribution Channel
- Hospital Pharmacies
- Drug Stores
- Online Sales
- Retail Pharmacies
- Hypermarket/ Supermarket